Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease:A Randomized, Double-Blind, Placebo-Controlled Study
Phase of Trial: Phase IV
Latest Information Update: 20 Aug 2015
Price : $35 *
At a glance
- Drugs Metformin (Primary)
- Indications Ischaemic heart disorders
- Focus Pharmacodynamics
- 17 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.
- 03 Jul 2013 New trial record
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.